Groups | After infection | After treatment | ||
---|---|---|---|---|
PCV (%) | RBC (106) | PCV (%) | RBC (106) | |
Group A | 31.8 ± 1.79 | 8.44 ± 0.52 | 41 ± 1.15 | 10.54 ± 0.31 |
Group B | 30.4 ± 2.07 | 8.51 ± 0.51 | 41 ± 1.83 | 9.90 ± 0.42 |
Group C | 27 ± 11.90 | 7.97 ± 0.76 | 42 ± 2.90 | 10.50 ± 0.12 |
Group D | 31.17 ± 3.60 | 7.87 ± 0.77 | 40.5 ± 3.11 | 10.39 ± 0.70 |
Group E | 32 ± 3.65 | 8.51 ± 0.13 | 36.67 ± 3.21 | 10.49 ± 0.17 |
Group F | 35.4 ± 3.71 | 7.08 ± 0.51 | 42.75 ± 2.22 | 10.36 ± 0.64 |
Group G | 21.4 ± 1.95 | 5.05 ± 0.42 | 34.4 ± 2.30 | 9.32 ± 0.41 |
Group H | 32.25 ± 3.30 | 6.60 ± 0.68 | 33.25 ± 2.75 | 8.76 ± 0.43 |
Group I | 30.67 ± 2.50 | 7.75 ± 0.96 | 31.2 ± 1.92 | 7.75 ± 0.53 |
Group J | 32.17 ± 2.71 | 6.76 ± 0.72 | 31.2 ± 1.30 | 7.5 ± 0.85 |
Group K | 30.20 ± 1.48 | 6.87 ± 0.50 | 28.67 ± 3.05 | 7.70 ± 0.74 |
Group L | 31.4 ± 1.67 | 7.10 ± 0.68 | 31.67 ± 1.53 | 7.44 ± 0.12 |
Group M | 24 ± 2.97 | 6.12 ± 0.49 | 35.6 ± 3.65 | 8.41 ± 1.25 |
Group N | 23.2 ± 3.03 | 5.67 ± 0.42 | 34.75 ± 3.59 | 6.61 ± 0.53 |
Group O | 49.5 ± 3.70 | 10.72 ± 0.14 | 48.25 ± 3.10 | 10.69 ± 0.24 |
Group P | 23.2 ± 3.83 | 5.93 ± 0.50 | 33.6 ± 3.58 | 8.43 ± 0.29 |